A Common Promoter Variant of TBX21 is Associated with Allele Specific Binding to Yin-Yang 1 and Redu

来源 :第三届全国病毒性肝炎慢性化重症化基础与临床研究进展学术会议 | 被引量 : 0次 | 上传用户:liuyi8431201
下载到本地 , 更方便阅读
声明 : 本文档内容版权归属内容提供方 , 如果您对本文有版权争议 , 可与客服联系进行内容授权或下架
论文部分内容阅读
  T-bet is a key regulator for the lineage commitment in CD4 T helper (Th) 1 cells by activating the hallmark production of interferon-c, and its expression level is linked to autoimmune, infectious, and allergic diseases.A T to C base substitution has been identified at position-1993 in the TBX21 (encoding T-bet) promoter and has been associated with asthma and systemic lupus erythematosus.This study aimed to investigate the molecular mechanisms responsible for the influence of the T-1993 C polymorphism on transcription and its functional effect by luciferase reporter, EMSAs, Chromatin immunoprecipitation assay, and flow cytometric analysis of intracellular T-bet, IFN-c and IL-4 expression in activated CD4+ T cells.The presence of a-1993T allele obviously increases promoter activity compared with that of a promoter with a-1993C allele.TBX21 promoter carrying-1993C allele possesses significantly stronger binding affinity to the Yin Yang 1 (YY1) transcription factor than that carrying -1993 T allele.YY1 overexpression decreased TBX21 promoter function in a T cell line, demonstrating that this element functions as a repressor.The C to T base exchange relieves the repression mediated by YY1.The individuals carrying-1993 C allele were determined to have significantly diminished expression of TBX21 and IFN-c and increased IL-4 production in cells compared with the individuals carrying-1993T allele (P < 0.05).These findings demonstrate that the TBX21 T-1993C polymorphism represses TBX21 expression and Thl cytokine production through control of YY1, which might result in the imbalance between Thl and Th2 immune responses in autoimmune or allergic diseases.
其他文献
慢性病毒性疾病(包括HBV)可引起肾脏损伤并与肾功能不全有关,感染HBV的患者肾移植后的生存率下降,且再次移植的需求增加。另一方面,肾功能受损又可能带来一系列的影响,如慢性肾脏疾病、甲状旁腺功能亢进、骨质疏松及药物毒性和治疗药物调整剂量等,同时与心血管疾病及糖尿病相互影响。目前文献报道CHB治疗所用核苷类似物如阿德福韦酯及替诺福韦均有一定的肾毒性可导致肾脏损伤,一些临床研究显示替比夫定单药或联合治
目的:本研究旨在通过检测乙肝相关性肝癌、乙肝相关性肝硬化、慢性乙型肝炎及正常人血清中的anti-Ku86的表达水平,明确anti-Ku86在乙肝相关性肝癌中的表达情况,并与甲胎蛋白(AFP)和α-L岩藻糖苷酶(AFU)的敏感度和特异度相比较.以明确anti-Ku86能否成为新的乙肝相关性肝癌血清标志物.方法:共收集哈尔滨医科大学附属第一医院就诊的57例乙肝相关性肝癌患者、48例乙肝肝硬化患者、52
目的:观察qFibrosis对于慢性乙肝活检样本大小相关采样误差的影响情况和程度,以初步判断其克服该传统组织学分析主要缺陷的能力。方法:分别对硫代乙酰胺诱导大鼠肝纤维化模型的各期肝组织样本和107例慢性乙肝各期肝活检样本进行纤维化胶原的结构图像采集,然后对于该信息使用qFibrosis进行分析评价。结果及结论:结果说明qFiibrosis对于样本大小不一的各期纤维化样本的准确识别能力优于形态测量法
目的:探讨干扰素治疗对慢性乙型肝炎(CHB)患者外周血单个核细胞(PBMCs)表达hTERT mRNA的影响.方法:用淋巴细胞分离液分离37例干扰素治疗CHB患者(干扰素治疗组),36例CHB对照患者(患者对照组)和10例健康人(健康对照组)的PBMCs,用Real-time PCR方法定量检测各组PBMCs的hTERTmRNA及其相应的β-actin mRNA,计算出标化的hTERTmRNA(N
目的:探讨慢性乙型肝炎(CHB)轻度患者ALT正常值二倍上下的肝脏组织学改变有无差异。方法:将CHB轻度患者120例,将HBeAg阳性和阴性的两种慢性乙型肝炎轻度患者按不同HBV DNA水平分组,再用ALT正常值上限的二倍(80U/L)分为ALT≥80U/L和ALT0.05)。结论:本研究结果显示,以HBeAg阳性或阴性的两种CHB轻度患者的不同HBV DNA水平分组的组织学改变的肝组织学改变比较
目的:探讨外周血髓源性抑制细胞(Myeloid-derived suppressor cells,MDSCs)在乙型肝炎病毒(HBV)相关慢加急性肝衰竭(ACLF)患者疾病进程中的临床意义.方法:入组45例HBV相关ACLF患者、34例慢性乙型肝炎(CHB)患者、25例健康对照者,采用流式细胞仪检测外周血MDSCs频率.对HBV相关ACLF患者进行为期3周的随访,动态观察外周血MDSCs的频率变化
目的:探讨分子信标探针转录介导的扩增技术(transcription mediatedamplification,TMA)与聚合酶链反应(polymerase chain reaction,PCR)检测丙型肝炎核糖核酸(Hepatitis C virus RNA,HCV RNA)灵敏性的差异,同时评价分子信标探针TMA体系试剂在不同储存温度条件下的稳定性.方法:使用分子信标探针,分别采用TMA检测
会议
会议
Hepatitis C virus (HCV) infection places a heavy burden on health care services worldwide.More than 80% of patients infected with HCV show chronic infection and immunosuppression, which may be due to